ARMP News and Press, Armata Pharmaceuticals Inc. From 08/14/23

Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , Aug. 14, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on p...

2023-08-02 10:17:25 ET Gainers: TRxADE HEALTH ( MEDS ) +60% . Armata Pharmaceuticals ( ARMP ) +17% . Teva Pharmaceutical Industries ( TEVA ) +13% . CareDx ( CDNA ) +9% . Mallinckrodt ( MNK ) +9% . Losers: Adamis Pharmaceut...

2023-07-27 08:38:02 ET Mersana Therapeutics ( MRSN ) -74% announces topline data from UPLIFT clinical trial in patients with platinum-resistant Ovarian Cancer and strategic reprioritization. Biohaven ( BHVN ) -27% . Yellow Corporation ( YELL ) -26% . ...

2023-07-26 12:59:58 ET Gainers: Vicor Corporation ( VICR ) +51% . Tupperware Brands Corporation ( TUP ) +43% . ABVC BioPharma ( ABVC ) +39% . Armata Pharmaceuticals ( ARMP ) +30% . PacWest Bancorp ( PACW ) +27% . XPeng ( XP...

2023-07-24 10:09:58 ET Gainers: Armata Pharmaceuticals ( ARMP ) +19% . Janux Therapeutics ( JANX ) +11% . Amylyx Pharmaceuticals ( AMLX ) +8% . Coherus BioSciences ( CHRS ) +7% . Nuwellis ( NUWE ) +7% . Losers: Kodiak...

2023-07-11 08:50:31 ET Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals ( NYSE: ARMP ) enters into a credit and security ...

Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics PR Newswire Signs new $25 million credit agreement and extension of existing secured convertible credit agreement Appoints world‐renowned ...

Armata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapy PR Newswire MARINA DEL REY, Calif. , May 31, 2023 /PRNewswire/ -- Armata Pharmaceuticals, In...

2023-05-18 07:30:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday! Moving stocks this morning are public offerings, earnings repo...

2023-05-11 17:46:10 ET Armata Pharmaceuticals press release ( NYSE: ARMP ): Q1 GAAP EPS of -$0.40. Revenue of $0.79M (-35.8% Y/Y). Cash and Equivalents. As of March 31, 2023, Armata held approximately $25.1 million of unrestricted cash and cash equivalents, as compar...